

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.44544287 |
| 2 | leukocyte aggregation (GO:0070486) | 5.25254432 |
| 3 | microglial cell activation (GO:0001774) | 5.11887540 |
| 4 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.02674269 |
| 5 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.91746547 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.75003261 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.74290515 |
| 8 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 4.36812991 |
| 9 | neutrophil activation (GO:0042119) | 4.29546055 |
| 10 | cellular extravasation (GO:0045123) | 4.29273414 |
| 11 | macrophage activation (GO:0042116) | 4.28855416 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.17239553 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 4.14740026 |
| 14 | granulocyte activation (GO:0036230) | 4.01974333 |
| 15 | respiratory burst (GO:0045730) | 4.00037878 |
| 16 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.93849814 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.93849814 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.93849814 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.93849814 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.93849814 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.93849814 |
| 22 | response to peptidoglycan (GO:0032494) | 3.80735312 |
| 23 | interferon-gamma production (GO:0032609) | 3.72205413 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.70145676 |
| 25 | polyketide metabolic process (GO:0030638) | 3.69622750 |
| 26 | doxorubicin metabolic process (GO:0044598) | 3.69622750 |
| 27 | daunorubicin metabolic process (GO:0044597) | 3.69622750 |
| 28 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.68096093 |
| 29 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.68096093 |
| 30 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.65434747 |
| 31 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.64121067 |
| 32 | myeloid leukocyte mediated immunity (GO:0002444) | 3.62512574 |
| 33 | immunoglobulin mediated immune response (GO:0016064) | 3.62050265 |
| 34 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.59819086 |
| 35 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.56569512 |
| 36 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.56229167 |
| 37 | regulation of B cell differentiation (GO:0045577) | 3.54180263 |
| 38 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.53396700 |
| 39 | superoxide anion generation (GO:0042554) | 3.52331079 |
| 40 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.51139781 |
| 41 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.50839016 |
| 42 | detection of molecule of bacterial origin (GO:0032490) | 3.48445875 |
| 43 | negative regulation of cell killing (GO:0031342) | 3.46443362 |
| 44 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46443362 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.45908819 |
| 46 | detection of other organism (GO:0098543) | 3.44762081 |
| 47 | positive thymic T cell selection (GO:0045059) | 3.43453988 |
| 48 | T cell migration (GO:0072678) | 3.39588388 |
| 49 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.36350012 |
| 50 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.34379090 |
| 51 | negative thymic T cell selection (GO:0045060) | 3.29208506 |
| 52 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.27706290 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.27611888 |
| 54 | response to interleukin-15 (GO:0070672) | 3.26445055 |
| 55 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.25276188 |
| 56 | negative T cell selection (GO:0043383) | 3.22881013 |
| 57 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21010026 |
| 58 | detection of bacterium (GO:0016045) | 3.20931963 |
| 59 | positive regulation of mast cell activation (GO:0033005) | 3.19325666 |
| 60 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.19253448 |
| 61 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.18347088 |
| 62 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.18347088 |
| 63 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.17792641 |
| 64 | myeloid cell activation involved in immune response (GO:0002275) | 3.16857989 |
| 65 | B cell receptor signaling pathway (GO:0050853) | 3.16134542 |
| 66 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.14358729 |
| 67 | regulation of interleukin-6 biosynthetic process (GO:0045408) | 3.14058500 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 3.12502033 |
| 69 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.12131277 |
| 70 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.11722053 |
| 71 | negative regulation of adaptive immune response (GO:0002820) | 3.11406727 |
| 72 | leukocyte degranulation (GO:0043299) | 3.11158940 |
| 73 | response to host immune response (GO:0052572) | 3.08913535 |
| 74 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.08913535 |
| 75 | neutrophil mediated immunity (GO:0002446) | 3.07395924 |
| 76 | positive regulation of interferon-alpha production (GO:0032727) | 3.07349945 |
| 77 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.07093561 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.05853370 |
| 79 | activated T cell proliferation (GO:0050798) | 3.05679797 |
| 80 | mast cell activation (GO:0045576) | 3.05139701 |
| 81 | regulation of mast cell activation (GO:0033003) | 3.04708650 |
| 82 | regulation of tolerance induction (GO:0002643) | 3.03966939 |
| 83 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.03921038 |
| 84 | myeloid dendritic cell activation (GO:0001773) | 3.03351550 |
| 85 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.03275443 |
| 86 | regulation of interferon-alpha production (GO:0032647) | 3.02016237 |
| 87 | positive regulation of B cell differentiation (GO:0045579) | 3.00993165 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00610910 |
| 89 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.00218998 |
| 90 | hepatocyte apoptotic process (GO:0097284) | 2.99232113 |
| 91 | defense response to protozoan (GO:0042832) | 2.98837199 |
| 92 | regulation of regulatory T cell differentiation (GO:0045589) | 2.98601426 |
| 93 | response to type I interferon (GO:0034340) | 2.98572911 |
| 94 | response to muramyl dipeptide (GO:0032495) | 2.97648711 |
| 95 | leukocyte cell-cell adhesion (GO:0007159) | 2.97073114 |
| 96 | cellular response to type I interferon (GO:0071357) | 2.96434830 |
| 97 | type I interferon signaling pathway (GO:0060337) | 2.96434830 |
| 98 | negative regulation of B cell mediated immunity (GO:0002713) | 2.96117736 |
| 99 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.96117736 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96050631 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.94833009 |
| 102 | thymic T cell selection (GO:0045061) | 2.93994636 |
| 103 | cellular response to zinc ion (GO:0071294) | 2.92739723 |
| 104 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.91519569 |
| 105 | macrophage activation involved in immune response (GO:0002281) | 2.90662786 |
| 106 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.90580928 |
| 107 | regulation of mast cell degranulation (GO:0043304) | 2.89894222 |
| 108 | negative regulation of T cell mediated immunity (GO:0002710) | 2.89868379 |
| 109 | regulation of antigen processing and presentation (GO:0002577) | 2.87472706 |
| 110 | T-helper 1 type immune response (GO:0042088) | 2.86995105 |
| 111 | negative regulation of mast cell activation (GO:0033004) | 2.86766447 |
| 112 | dendritic cell migration (GO:0036336) | 2.85235959 |
| 113 | tolerance induction (GO:0002507) | 2.85006516 |
| 114 | response to protozoan (GO:0001562) | 2.84847980 |
| 115 | detection of biotic stimulus (GO:0009595) | 2.84791402 |
| 116 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.84676729 |
| 117 | positive T cell selection (GO:0043368) | 2.84284735 |
| 118 | dendritic cell chemotaxis (GO:0002407) | 2.82714235 |
| 119 | T cell selection (GO:0045058) | 2.82495901 |
| 120 | negative regulation of B cell proliferation (GO:0030889) | 2.82063610 |
| 121 | myeloid leukocyte activation (GO:0002274) | 2.79929171 |
| 122 | cellular defense response (GO:0006968) | 2.78968233 |
| 123 | positive regulation of macrophage differentiation (GO:0045651) | 2.78418529 |
| 124 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.75464660 |
| 125 | neutrophil chemotaxis (GO:0030593) | 2.75416734 |
| 126 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.74950225 |
| 127 | response to host (GO:0075136) | 2.74950225 |
| 128 | response to host defenses (GO:0052200) | 2.74950225 |
| 129 | negative regulation of phagocytosis (GO:0050765) | 2.72735492 |
| 130 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.71876507 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.94762868 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.68603740 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.66611982 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.43219119 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.04727999 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.00343363 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.79410713 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.65530094 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.54436992 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.49931597 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.26340392 |
| 12 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.16374898 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.92490489 |
| 14 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.89267885 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.85405879 |
| 16 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.83783850 |
| 17 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.78116015 |
| 18 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.68039282 |
| 19 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.46356076 |
| 20 | MYB_26560356_Chip-Seq_TH2_Human | 2.43564549 |
| 21 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.40890300 |
| 22 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.37394599 |
| 23 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.19972402 |
| 24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18561611 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.11006802 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.01911263 |
| 27 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.97570200 |
| 28 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.94901392 |
| 29 | MYB_26560356_Chip-Seq_TH1_Human | 1.94727483 |
| 30 | MAF_26560356_Chip-Seq_TH1_Human | 1.91263213 |
| 31 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.86439205 |
| 32 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84934870 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82719809 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.80577546 |
| 35 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77231672 |
| 36 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69296764 |
| 37 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.68575135 |
| 38 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.68276633 |
| 39 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63324996 |
| 40 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.62889653 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.60081028 |
| 42 | SPI1_23127762_ChIP-Seq_K562_Human | 1.53907317 |
| 43 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.52513238 |
| 44 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50918073 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.50896870 |
| 46 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.50602997 |
| 47 | GATA3_26560356_Chip-Seq_TH2_Human | 1.50041146 |
| 48 | UTX_26944678_Chip-Seq_JUKART_Human | 1.48205853 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.46796523 |
| 50 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.45424085 |
| 51 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42494417 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.42134844 |
| 53 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41945020 |
| 54 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41040401 |
| 55 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36734292 |
| 56 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35967345 |
| 57 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34429368 |
| 58 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.33812565 |
| 59 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29224350 |
| 60 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.24542006 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.22974396 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.19466323 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17869001 |
| 64 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16822853 |
| 65 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14429428 |
| 66 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13212106 |
| 67 | MYC_22102868_ChIP-Seq_BL_Human | 1.13043206 |
| 68 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11288309 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04893449 |
| 70 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03679692 |
| 71 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.03198910 |
| 72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02894740 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 0.98613859 |
| 74 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.96742648 |
| 75 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95494072 |
| 76 | RXR_22108803_ChIP-Seq_LS180_Human | 0.93384970 |
| 77 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.93138361 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91019797 |
| 79 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86416310 |
| 80 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85329060 |
| 81 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84939080 |
| 82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.84113249 |
| 83 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83266457 |
| 84 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.82031588 |
| 85 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.81395917 |
| 86 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.81238863 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80725880 |
| 88 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.79813383 |
| 89 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.79344150 |
| 90 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79322509 |
| 91 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.79052906 |
| 92 | GATA3_26560356_Chip-Seq_TH1_Human | 0.79042000 |
| 93 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.78832252 |
| 94 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.78832252 |
| 95 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78408507 |
| 96 | * GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78000578 |
| 97 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.77605590 |
| 98 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.76931752 |
| 99 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.76403137 |
| 100 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75799925 |
| 101 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.73831299 |
| 102 | GATA2_19941826_ChIP-Seq_K562_Human | 0.73343038 |
| 103 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.73270072 |
| 104 | * KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.72200204 |
| 105 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.71577168 |
| 106 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71377866 |
| 107 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71336422 |
| 108 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70634488 |
| 109 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.70406602 |
| 110 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.69079917 |
| 111 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.68962932 |
| 112 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.68955212 |
| 113 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.68882992 |
| 114 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.68147013 |
| 115 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.66646557 |
| 116 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.65401703 |
| 117 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.65292915 |
| 118 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.64652305 |
| 119 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.64551360 |
| 120 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.64406828 |
| 121 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.63718242 |
| 122 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.61592425 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.60459267 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.45533458 |
| 2 | MP0003436_decreased_susceptibility_to | 3.73641791 |
| 3 | MP0005671_abnormal_response_to | 3.45588972 |
| 4 | MP0009785_altered_susceptibility_to | 3.41993737 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.17698210 |
| 6 | MP0001790_abnormal_immune_system | 3.10889999 |
| 7 | MP0005387_immune_system_phenotype | 3.10889999 |
| 8 | MP0005000_abnormal_immune_tolerance | 3.04816214 |
| 9 | MP0001800_abnormal_humoral_immune | 3.02544802 |
| 10 | MP0002419_abnormal_innate_immunity | 2.97917099 |
| 11 | MP0005025_abnormal_response_to | 2.88486076 |
| 12 | MP0002452_abnormal_antigen_presenting | 2.85884794 |
| 13 | MP0000685_abnormal_immune_system | 2.74413140 |
| 14 | MP0002723_abnormal_immune_serum | 2.70160780 |
| 15 | MP0003303_peritoneal_inflammation | 2.69182519 |
| 16 | MP0001819_abnormal_immune_cell | 2.63842793 |
| 17 | MP0002420_abnormal_adaptive_immunity | 2.63085148 |
| 18 | MP0003763_abnormal_thymus_physiology | 2.44400330 |
| 19 | MP0006082_CNS_inflammation | 2.41749532 |
| 20 | MP0003724_increased_susceptibility_to | 2.25477541 |
| 21 | MP0002405_respiratory_system_inflammati | 2.21308293 |
| 22 | MP0002398_abnormal_bone_marrow | 2.05373578 |
| 23 | MP0005464_abnormal_platelet_physiology | 2.01393540 |
| 24 | MP0004947_skin_inflammation | 2.00783595 |
| 25 | MP0000716_abnormal_immune_system | 2.00105026 |
| 26 | MP0001853_heart_inflammation | 1.99873426 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.92472289 |
| 28 | MP0001533_abnormal_skeleton_physiology | 1.90109712 |
| 29 | MP0002933_joint_inflammation | 1.90087226 |
| 30 | MP0002006_tumorigenesis | 1.82435868 |
| 31 | MP0001845_abnormal_inflammatory_respons | 1.82188199 |
| 32 | MP0004883_abnormal_blood_vessel | 1.79907488 |
| 33 | MP0005310_abnormal_salivary_gland | 1.76722586 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.73425099 |
| 35 | MP0000569_abnormal_digit_pigmentation | 1.72055008 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.71536479 |
| 37 | MP0001873_stomach_inflammation | 1.64978010 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.64292175 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.64041493 |
| 40 | MP0002429_abnormal_blood_cell | 1.61431745 |
| 41 | MP0004510_myositis | 1.61168247 |
| 42 | MP0002722_abnormal_immune_system | 1.61048658 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.60618611 |
| 44 | MP0000858_altered_metastatic_potential | 1.50584402 |
| 45 | MP0002277_abnormal_respiratory_mucosa | 1.50405784 |
| 46 | MP0009764_decreased_sensitivity_to | 1.50293794 |
| 47 | MP0009278_abnormal_bone_marrow | 1.44332998 |
| 48 | MP0004381_abnormal_hair_follicle | 1.44039987 |
| 49 | MP0005058_abnormal_lysosome_morphology | 1.41430961 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.39611055 |
| 51 | MP0005451_abnormal_body_composition | 1.37799369 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.36302356 |
| 53 | MP0005164_abnormal_response_to | 1.35647494 |
| 54 | MP0003448_altered_tumor_morphology | 1.35115268 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.31898790 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.31898790 |
| 57 | MP0000343_altered_response_to | 1.30821946 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.28744045 |
| 59 | MP0000490_abnormal_crypts_of | 1.26011296 |
| 60 | MP0003172_abnormal_lysosome_physiology | 1.24823659 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.24818007 |
| 62 | MP0008469_abnormal_protein_level | 1.23747847 |
| 63 | MP0000015_abnormal_ear_pigmentation | 1.23705645 |
| 64 | MP0003300_gastrointestinal_ulcer | 1.21406494 |
| 65 | MP0001851_eye_inflammation | 1.20649545 |
| 66 | MP0002132_abnormal_respiratory_system | 1.20245003 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.20042517 |
| 68 | MP0004782_abnormal_surfactant_physiolog | 1.19626696 |
| 69 | MP0003866_abnormal_defecation | 1.13777505 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.11880637 |
| 71 | MP0003787_abnormal_imprinting | 1.08845035 |
| 72 | MP0005075_abnormal_melanosome_morpholog | 1.06736881 |
| 73 | MP0005390_skeleton_phenotype | 1.06070676 |
| 74 | MP0008004_abnormal_stomach_pH | 1.04621106 |
| 75 | MP0003828_pulmonary_edema | 0.97956278 |
| 76 | MP0003453_abnormal_keratinocyte_physiol | 0.96965509 |
| 77 | MP0002095_abnormal_skin_pigmentation | 0.96672686 |
| 78 | MP0005166_decreased_susceptibility_to | 0.95402541 |
| 79 | MP0004484_altered_response_of | 0.92615802 |
| 80 | MP0003045_fibrosis | 0.91315817 |
| 81 | MP0003795_abnormal_bone_structure | 0.91128715 |
| 82 | MP0003566_abnormal_cell_adhesion | 0.86152485 |
| 83 | MP0003690_abnormal_glial_cell | 0.83992645 |
| 84 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82665966 |
| 85 | MP0002332_abnormal_exercise_endurance | 0.82377282 |
| 86 | MP0001216_abnormal_epidermal_layer | 0.81860453 |
| 87 | MP0004130_abnormal_muscle_cell | 0.80730937 |
| 88 | MP0003075_altered_response_to | 0.79292852 |
| 89 | MP0002928_abnormal_bile_duct | 0.78074366 |
| 90 | MP0000427_abnormal_hair_cycle | 0.77989780 |
| 91 | MP0001663_abnormal_digestive_system | 0.74257549 |
| 92 | MP0003252_abnormal_bile_duct | 0.72864354 |
| 93 | MP0000371_diluted_coat_color | 0.71699693 |
| 94 | MP0001191_abnormal_skin_condition | 0.71676864 |
| 95 | MP0008877_abnormal_DNA_methylation | 0.70691393 |
| 96 | MP0001986_abnormal_taste_sensitivity | 0.70599818 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.66858889 |
| 98 | MP0009765_abnormal_xenobiotic_induced | 0.66569200 |
| 99 | MP0003941_abnormal_skin_development | 0.65790058 |
| 100 | MP0002254_reproductive_system_inflammat | 0.64571108 |
| 101 | MP0003279_aneurysm | 0.63771068 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 0.62799439 |
| 103 | MP0008057_abnormal_DNA_replication | 0.60786230 |
| 104 | MP0002133_abnormal_respiratory_system | 0.60749982 |
| 105 | MP0005388_respiratory_system_phenotype | 0.60749982 |
| 106 | MP0009763_increased_sensitivity_to | 0.60399262 |
| 107 | MP0005376_homeostasis/metabolism_phenot | 0.59316887 |
| 108 | MP0002098_abnormal_vibrissa_morphology | 0.58704392 |
| 109 | MP0002019_abnormal_tumor_incidence | 0.57620603 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.56846272 |
| 111 | MP0008260_abnormal_autophagy | 0.56476925 |
| 112 | MP0000604_amyloidosis | 0.55595248 |
| 113 | MP0005076_abnormal_cell_differentiation | 0.54013207 |
| 114 | MP0002060_abnormal_skin_morphology | 0.53729172 |
| 115 | MP0010386_abnormal_urinary_bladder | 0.53673718 |
| 116 | MP0002009_preneoplasia | 0.53627970 |
| 117 | MP0002796_impaired_skin_barrier | 0.53325055 |
| 118 | MP0000367_abnormal_coat/_hair | 0.52917063 |
| 119 | MP0006054_spinal_hemorrhage | 0.52385044 |
| 120 | MP0009931_abnormal_skin_appearance | 0.52155330 |
| 121 | MP0000372_irregular_coat_pigmentation | 0.52020538 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.51732270 |
| 123 | MP0000249_abnormal_blood_vessel | 0.51123968 |
| 124 | MP0005023_abnormal_wound_healing | 0.50179423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.31599189 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.14610686 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.43042982 |
| 4 | Gastrointestinal infarctions (HP:0005244) | 4.57942754 |
| 5 | Myositis (HP:0100614) | 4.57634512 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.38211189 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 4.18240118 |
| 8 | Recurrent fungal infections (HP:0002841) | 4.08088348 |
| 9 | Optic neuritis (HP:0100653) | 4.01791636 |
| 10 | Retrobulbar optic neuritis (HP:0100654) | 4.01791636 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.97659108 |
| 12 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.96678866 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 3.95612210 |
| 14 | Obstructive lung disease (HP:0006536) | 3.95612210 |
| 15 | Stomatitis (HP:0010280) | 3.90013239 |
| 16 | Orchitis (HP:0100796) | 3.79729080 |
| 17 | Recurrent skin infections (HP:0001581) | 3.77327526 |
| 18 | Recurrent cutaneous fungal infections (HP:0011370) | 3.62875881 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.62875881 |
| 20 | Meningitis (HP:0001287) | 3.57918280 |
| 21 | IgM deficiency (HP:0002850) | 3.48965414 |
| 22 | Gingivitis (HP:0000230) | 3.48537372 |
| 23 | Recurrent viral infections (HP:0004429) | 3.40971280 |
| 24 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.37736105 |
| 25 | Chest pain (HP:0100749) | 3.35831605 |
| 26 | Agammaglobulinemia (HP:0004432) | 3.33306208 |
| 27 | Vacuolated lymphocytes (HP:0001922) | 3.32650622 |
| 28 | Vasculitis (HP:0002633) | 3.29025965 |
| 29 | Chronic otitis media (HP:0000389) | 3.26728881 |
| 30 | Recurrent pneumonia (HP:0006532) | 3.26188705 |
| 31 | Peritonitis (HP:0002586) | 3.25050545 |
| 32 | Cellulitis (HP:0100658) | 3.09258364 |
| 33 | Hypochromic microcytic anemia (HP:0004840) | 3.05686429 |
| 34 | Cheilitis (HP:0100825) | 2.95475060 |
| 35 | Pustule (HP:0200039) | 2.92174629 |
| 36 | Urticaria (HP:0001025) | 2.87951678 |
| 37 | Recurrent bronchitis (HP:0002837) | 2.85944478 |
| 38 | Anorexia (HP:0002039) | 2.84943402 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.84656461 |
| 40 | Recurrent sinusitis (HP:0011108) | 2.79173459 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.78253346 |
| 42 | Pulmonary embolism (HP:0002204) | 2.77986067 |
| 43 | T lymphocytopenia (HP:0005403) | 2.77692272 |
| 44 | Parakeratosis (HP:0001036) | 2.76749200 |
| 45 | Hypochromic anemia (HP:0001931) | 2.73291353 |
| 46 | Periodontitis (HP:0000704) | 2.71247920 |
| 47 | Lymphopenia (HP:0001888) | 2.68927748 |
| 48 | Episodic fever (HP:0001954) | 2.67678445 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.65696205 |
| 50 | Hemoptysis (HP:0002105) | 2.65202059 |
| 51 | Recurrent lower respiratory tract infections (HP:0002783) | 2.63857643 |
| 52 | Thyroiditis (HP:0100646) | 2.62944221 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.62415348 |
| 54 | Prostate neoplasm (HP:0100787) | 2.61949694 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 2.61901008 |
| 56 | Chronic diarrhea (HP:0002028) | 2.61676030 |
| 57 | Abnormality of B cell number (HP:0010975) | 2.60920987 |
| 58 | B lymphocytopenia (HP:0010976) | 2.60920987 |
| 59 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.57740643 |
| 60 | Abnormality of T cells (HP:0002843) | 2.56966977 |
| 61 | Osteomyelitis (HP:0002754) | 2.56383946 |
| 62 | Petechiae (HP:0000967) | 2.54643087 |
| 63 | Erythema (HP:0010783) | 2.54158924 |
| 64 | Keratoconjunctivitis sicca (HP:0001097) | 2.52685063 |
| 65 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50759072 |
| 66 | Granulocytopenia (HP:0001913) | 2.49385286 |
| 67 | Autoimmune thrombocytopenia (HP:0001973) | 2.47578896 |
| 68 | Subacute progressive viral hepatitis (HP:0006572) | 2.44326203 |
| 69 | Colitis (HP:0002583) | 2.44037548 |
| 70 | Arterial thrombosis (HP:0004420) | 2.43674939 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.42564483 |
| 72 | Abnormality of the prostate (HP:0008775) | 2.41592098 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 2.37526257 |
| 74 | Autoimmune hemolytic anemia (HP:0001890) | 2.36812535 |
| 75 | Gastrointestinal stroma tumor (HP:0100723) | 2.36791686 |
| 76 | Abnormality of T cell physiology (HP:0011840) | 2.36726009 |
| 77 | Prolonged bleeding time (HP:0003010) | 2.36394079 |
| 78 | Leukocytosis (HP:0001974) | 2.33319039 |
| 79 | Keratoconjunctivitis (HP:0001096) | 2.28660406 |
| 80 | Severe combined immunodeficiency (HP:0004430) | 2.27999251 |
| 81 | Panhypogammaglobulinemia (HP:0003139) | 2.25811394 |
| 82 | IgG deficiency (HP:0004315) | 2.25656713 |
| 83 | Gingival bleeding (HP:0000225) | 2.20585327 |
| 84 | Microcytic anemia (HP:0001935) | 2.19337177 |
| 85 | Increased IgM level (HP:0003496) | 2.19294744 |
| 86 | Abnormality of the peritoneum (HP:0002585) | 2.19143057 |
| 87 | Sepsis (HP:0100806) | 2.18440598 |
| 88 | Viral hepatitis (HP:0006562) | 2.18314044 |
| 89 | Increased IgE level (HP:0003212) | 2.17193078 |
| 90 | Skin ulcer (HP:0200042) | 2.15004167 |
| 91 | Abnormality of the endocardium (HP:0004306) | 2.14278994 |
| 92 | Gangrene (HP:0100758) | 2.13100235 |
| 93 | Basal ganglia calcification (HP:0002135) | 2.12667144 |
| 94 | Stomach cancer (HP:0012126) | 2.11760008 |
| 95 | Amyloidosis (HP:0011034) | 2.11120229 |
| 96 | Epistaxis (HP:0000421) | 2.11047736 |
| 97 | Hypergammaglobulinemia (HP:0010702) | 2.09848146 |
| 98 | Acute hepatic failure (HP:0006554) | 2.09494498 |
| 99 | Abnormality of eosinophils (HP:0001879) | 2.07673201 |
| 100 | Encephalitis (HP:0002383) | 2.05186580 |
| 101 | Vertigo (HP:0002321) | 2.04134105 |
| 102 | Glomerulopathy (HP:0100820) | 2.03290468 |
| 103 | Papilloma (HP:0012740) | 2.02953849 |
| 104 | Verrucae (HP:0200043) | 2.02953849 |
| 105 | Combined immunodeficiency (HP:0005387) | 1.99482378 |
| 106 | Keratitis (HP:0000491) | 1.97887654 |
| 107 | Skin rash (HP:0000988) | 1.97874738 |
| 108 | Slow saccadic eye movements (HP:0000514) | 1.97381377 |
| 109 | Thick nail (HP:0001805) | 1.96944321 |
| 110 | Thrombocytosis (HP:0001894) | 1.96683465 |
| 111 | Arthralgia (HP:0002829) | 1.96347798 |
| 112 | Eosinophilia (HP:0001880) | 1.94887758 |
| 113 | IgA deficiency (HP:0002720) | 1.93647823 |
| 114 | Premature loss of primary teeth (HP:0006323) | 1.93089355 |
| 115 | Absent frontal sinuses (HP:0002688) | 1.92777373 |
| 116 | Chronic sinusitis (HP:0011109) | 1.91529764 |
| 117 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91388845 |
| 118 | Restrictive lung disease (HP:0002091) | 1.90806707 |
| 119 | Joint swelling (HP:0001386) | 1.88004589 |
| 120 | Abnormality of the pericardium (HP:0001697) | 1.86078142 |
| 121 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.85975822 |
| 122 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.85975822 |
| 123 | Abnormality of glycolipid metabolism (HP:0010969) | 1.85975822 |
| 124 | Ectropion (HP:0000656) | 1.82085318 |
| 125 | Acne (HP:0001061) | 1.79352899 |
| 126 | Papilledema (HP:0001085) | 1.78110069 |
| 127 | Spontaneous hematomas (HP:0007420) | 1.78002075 |
| 128 | Abnormality of the pleura (HP:0002103) | 1.76738233 |
| 129 | Polyneuropathy (HP:0001271) | 1.76358978 |
| 130 | Emphysema (HP:0002097) | 1.75639658 |
| 131 | Thrombophlebitis (HP:0004418) | 1.74575437 |
| 132 | Alveolar cell carcinoma (HP:0006519) | 1.72288511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.96662641 |
| 2 | MAP4K1 | 3.85351812 |
| 3 | IRAK4 | 3.50244942 |
| 4 | MAP3K14 | 3.48364284 |
| 5 | BLK | 3.00850657 |
| 6 | SIK3 | 2.90413159 |
| 7 | IRAK3 | 2.67396285 |
| 8 | RIPK4 | 2.62604426 |
| 9 | IKBKE | 2.39503626 |
| 10 | TYK2 | 2.38704920 |
| 11 | TBK1 | 2.29729027 |
| 12 | TEC | 2.28409651 |
| 13 | JAK3 | 2.25036670 |
| 14 | KIT | 2.21789803 |
| 15 | FRK | 1.99141875 |
| 16 | MAP3K13 | 1.96206289 |
| 17 | IKBKB | 1.90233679 |
| 18 | BTK | 1.88644432 |
| 19 | ZAP70 | 1.87009589 |
| 20 | ITK | 1.85368697 |
| 21 | NME2 | 1.70124574 |
| 22 | STK10 | 1.69474698 |
| 23 | MAP3K2 | 1.66817631 |
| 24 | MAP3K12 | 1.65872442 |
| 25 | SYK | 1.65400604 |
| 26 | JAK1 | 1.63763474 |
| 27 | HCK | 1.47737460 |
| 28 | TRPM7 | 1.42835936 |
| 29 | MST4 | 1.40305493 |
| 30 | LCK | 1.36881127 |
| 31 | STK24 | 1.35840223 |
| 32 | SIK2 | 1.35458715 |
| 33 | CSK | 1.34274409 |
| 34 | TGFBR2 | 1.31683261 |
| 35 | CLK1 | 1.26824938 |
| 36 | LYN | 1.25727723 |
| 37 | MARK3 | 1.23658589 |
| 38 | MAP3K3 | 1.23368693 |
| 39 | ERN1 | 1.22503108 |
| 40 | CSF1R | 1.21751813 |
| 41 | TAOK1 | 1.21724077 |
| 42 | KSR2 | 1.21012327 |
| 43 | PTK2B | 1.17935207 |
| 44 | PIM1 | 1.16317980 |
| 45 | CHUK | 1.14735889 |
| 46 | MAP3K1 | 1.14233267 |
| 47 | TAOK3 | 1.13863847 |
| 48 | PIM2 | 1.13467555 |
| 49 | MAP3K6 | 1.12837899 |
| 50 | FGFR3 | 1.04910525 |
| 51 | RPS6KA4 | 0.96286712 |
| 52 | NLK | 0.95770287 |
| 53 | WNK1 | 0.94576382 |
| 54 | BMPR2 | 0.94229149 |
| 55 | MAP2K3 | 0.93851516 |
| 56 | ADRBK2 | 0.89985672 |
| 57 | YES1 | 0.89869823 |
| 58 | FES | 0.88470981 |
| 59 | NEK9 | 0.87934063 |
| 60 | ERBB3 | 0.87086275 |
| 61 | TNK2 | 0.85590360 |
| 62 | CDK19 | 0.79589735 |
| 63 | PDK1 | 0.78737719 |
| 64 | CAMKK2 | 0.78036326 |
| 65 | SGK3 | 0.77690616 |
| 66 | PRKCQ | 0.76621102 |
| 67 | TAOK2 | 0.76492978 |
| 68 | MARK2 | 0.75478852 |
| 69 | FGFR4 | 0.74287297 |
| 70 | RAF1 | 0.73671031 |
| 71 | PIK3CG | 0.73485809 |
| 72 | MAP2K4 | 0.72829029 |
| 73 | STK11 | 0.72012018 |
| 74 | GRK6 | 0.71609215 |
| 75 | EIF2AK2 | 0.70384935 |
| 76 | GRK7 | 0.67964895 |
| 77 | IRAK2 | 0.67916260 |
| 78 | ACVR1B | 0.67602085 |
| 79 | SIK1 | 0.66490181 |
| 80 | IRAK1 | 0.66328888 |
| 81 | JAK2 | 0.66109315 |
| 82 | KDR | 0.64227739 |
| 83 | KSR1 | 0.63651932 |
| 84 | MAP3K7 | 0.61468764 |
| 85 | PRKG2 | 0.60465028 |
| 86 | PTK6 | 0.59328872 |
| 87 | STK38 | 0.57372630 |
| 88 | EPHB1 | 0.55270744 |
| 89 | FLT3 | 0.53830188 |
| 90 | LRRK2 | 0.52678205 |
| 91 | STK4 | 0.52368228 |
| 92 | MATK | 0.51963948 |
| 93 | FGR | 0.51738522 |
| 94 | ABL1 | 0.51416121 |
| 95 | NUAK1 | 0.51334587 |
| 96 | PRKCD | 0.51206170 |
| 97 | ADRBK1 | 0.50749449 |
| 98 | MAP3K11 | 0.50367115 |
| 99 | PDPK1 | 0.49831279 |
| 100 | PRKD2 | 0.47930219 |
| 101 | PRPF4B | 0.47757538 |
| 102 | GRK1 | 0.46397918 |
| 103 | GRK5 | 0.44920808 |
| 104 | MAPK12 | 0.43578346 |
| 105 | EPHA3 | 0.42468812 |
| 106 | BMPR1B | 0.41786022 |
| 107 | CDK3 | 0.41618549 |
| 108 | RPS6KA6 | 0.41255611 |
| 109 | MAPKAPK2 | 0.40404011 |
| 110 | DYRK3 | 0.40166478 |
| 111 | MAPK7 | 0.39421443 |
| 112 | SGK494 | 0.39214906 |
| 113 | SGK223 | 0.39214906 |
| 114 | OXSR1 | 0.38916225 |
| 115 | CAMKK1 | 0.38147434 |
| 116 | RET | 0.38048139 |
| 117 | MAP3K5 | 0.35845617 |
| 118 | PAK3 | 0.35452791 |
| 119 | PBK | 0.35252186 |
| 120 | BRD4 | 0.35186562 |
| 121 | ERBB2 | 0.33692358 |
| 122 | FYN | 0.32713444 |
| 123 | PRKCZ | 0.32619999 |
| 124 | DYRK1B | 0.32153421 |
| 125 | MAP2K6 | 0.32043333 |
| 126 | IGF1R | 0.31660916 |
| 127 | SGK2 | 0.30658316 |
| 128 | RPS6KL1 | 0.30457171 |
| 129 | RPS6KC1 | 0.30457171 |
| 130 | SGK1 | 0.28816997 |
| 131 | PRKCH | 0.28556249 |
| 132 | ZAK | 0.28471759 |
| 133 | CDK8 | 0.28251797 |
| 134 | HIPK2 | 0.23204771 |
| 135 | INSRR | 0.22066716 |
| 136 | INSR | 0.21511426 |
| 137 | MAPK3 | 0.21168017 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.01604949 |
| 2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.90318508 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.84445605 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.74953251 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.58252235 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.58237800 |
| 7 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.35527804 |
| 8 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.22816895 |
| 9 | Measles_Homo sapiens_hsa05162 | 2.22521068 |
| 10 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.18430222 |
| 11 | Allograft rejection_Homo sapiens_hsa05330 | 2.17848935 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.08681141 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.06789810 |
| 14 | Asthma_Homo sapiens_hsa05310 | 2.02111310 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93427116 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.83858447 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.77616574 |
| 18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.75756823 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.74405976 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72021719 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.67981410 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.67800076 |
| 23 | Legionellosis_Homo sapiens_hsa05134 | 1.66202572 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.66064093 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.62632334 |
| 26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62298833 |
| 27 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.53633360 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.53479158 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.51921308 |
| 30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43685152 |
| 31 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41628367 |
| 32 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.41398421 |
| 33 | Influenza A_Homo sapiens_hsa05164 | 1.40221228 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.36312853 |
| 35 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.31299567 |
| 36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.30818832 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.26890178 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.26258240 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.25960273 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.17293087 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.16517474 |
| 42 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15936337 |
| 43 | Phagosome_Homo sapiens_hsa04145 | 1.13163772 |
| 44 | Salmonella infection_Homo sapiens_hsa05132 | 1.12773158 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10155316 |
| 46 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07855311 |
| 47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.06691787 |
| 48 | Viral myocarditis_Homo sapiens_hsa05416 | 1.03994798 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.02671972 |
| 50 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98853661 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.95924172 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.94169161 |
| 53 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.92843001 |
| 54 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90582215 |
| 55 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88229028 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 0.86695264 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.85675639 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.83286266 |
| 59 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.83085430 |
| 60 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.81417702 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80277905 |
| 62 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.77745514 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.73448887 |
| 64 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64056395 |
| 65 | Endometrial cancer_Homo sapiens_hsa05213 | 0.63835205 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.62634326 |
| 67 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61897152 |
| 68 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.61098294 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.60691097 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.60575533 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.60509196 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60121421 |
| 73 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59503599 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58963548 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58649987 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.55583484 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54662105 |
| 78 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53932003 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.53548898 |
| 80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52592462 |
| 81 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52226145 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50449030 |
| 83 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49989942 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.48778075 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.48575647 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48445328 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.47478390 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46604908 |
| 89 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45062031 |
| 90 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.44592894 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44182689 |
| 92 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42890856 |
| 93 | Glioma_Homo sapiens_hsa05214 | 0.41803999 |
| 94 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39913488 |
| 95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37994024 |
| 96 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.36672026 |
| 97 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.36374897 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.35130215 |
| 99 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.33963211 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.33884525 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.32471442 |
| 102 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.30495229 |
| 103 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.27694286 |
| 104 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.27233623 |
| 105 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.26920305 |
| 106 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26879150 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26013677 |
| 108 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25945723 |
| 109 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24999775 |
| 110 | Adherens junction_Homo sapiens_hsa04520 | 0.24364234 |
| 111 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.24335639 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23558010 |
| 113 | Prostate cancer_Homo sapiens_hsa05215 | 0.23119478 |
| 114 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.22454142 |
| 115 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21833661 |
| 116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.21416872 |
| 117 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.21218831 |
| 118 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20362143 |
| 119 | Colorectal cancer_Homo sapiens_hsa05210 | 0.20106302 |
| 120 | Endocytosis_Homo sapiens_hsa04144 | 0.20097944 |

